shBTG2 caused a notable increase in the expression of the cell cycle proteins Cyclin D1 and CDK4, while GV-BTG2 decreased Cyclin D1, CDK4 and CDK2 expression in ovarian cancer cells. The gene discussed is CDK4; the disease is ovarian carcinoma.